CDRE on NYSE
Cadre Holdings, Inc.
In its 2026 annual report the company says: “We are a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets. Our equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Through our dedication to superior quality, we establish a direct covenant with end users that our products will perform and keep them safe when they are most needed.”4 It is headquartered in Jacksonville, Florida.1 Its shares trade on NYSE under the symbol CDRE.1
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Avanos Medical, Invacare or Bone Biologics Corp, or pick any stock.
- TickerCDRE on NYSE1
- IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies1
- HeadquartersJacksonville, Florida1
- Incorporated inDE2
- Business address13386 International Pkwy, Jacksonville, Fl 322182
- Filer category, Emerging growth company2
See how the biggest companies compare on our leaderboards
We are a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets. Our equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Through our dedication to superior quality, we establish a direct covenant with end users that our products will perform and keep them safe when they are most needed. We sell a wide range of products including body armor, explosive ordnance disposal equipment , duty gear, remote handling solutions, containers for the storage of radioactive materials, and ventilation and containment solutions through both direct and indirect channels. In addition, through our owned distribution, we serve as a one-stop shop for first responders providi…4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
42.5%Gross margin5
11.0%Operating margin5
7.2%Net margin5
7.5%Revenue growth, 20255
13.9%Return on equity5
0.92×Debt to equity5
$56.8MFree cash flow5
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Products brought in 84% of the revenue Cadre Holdings, Inc. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Products | $410.8M | $497.6M | $543.7M |
| Distribution Services | $102.4M | $105.4M | $104.9M |
Regions
United States brought in 76% of the revenue Cadre Holdings, Inc. broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $385.5M | $455.2M | $461.4M |
| Outside the United States | $97.1M | $112.3M | $148.9M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue58¢$350.7M
- Research and development2¢$11.4M
- Selling, general and admin30¢$183.1M
- Income tax3¢$18.2M
- Profit7¢$44.1M
Out of $610.3M in revenue.5
Where each dollar of operating cash went, fiscal 2025
- Capital spending11¢$6.9M
- Dividends paid24¢$15.4M
- Kept or used elsewhere65¢$41.4M
Out of $63.7M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net sales | $610.3M | $567.6M | $482.5M |
| Cost of goods sold | $350.7M | $334.1M | $281.8M |
| Gross profit | $259.6M | $233.5M | $200.7M |
| Selling, general and administrative | $183.1M | $158.3M | $140.5M |
| Restructuring and transaction costs | $7.7M | $6.0M | $2.2M |
| Related party expense | $1.5M | $2.4M | $1.5M |
| Total operating expenses | $192.3M | $166.7M | $144.2M |
| Operating income | $67.4M | $66.8M | $56.5M |
| Interest expense, net | -$12.5M | -$7.8M | -$4.5M |
| Other income (expense), net | $7.5M | -$4.7M | $936.0K |
| Total other expense, net | -$5.0M | -$12.5M | -$3.6M |
| Income before provision for income taxes | $62.3M | $54.2M | $52.9M |
| Provision for income taxes | -$18.2M | -$18.1M | -$14.3M |
| Net income | $44.1M | $36.1M | $38.6M |
| Basic | $1.08 | $0.90 | $1.03 |
| Diluted | $1.02 | $0.90 | $1.02 |
| Basic | 40.9M shares | 39.9M shares | 37.5M shares |
| Diluted | 43.4M shares | 40.3M shares | 37.9M shares |
| Unrealized holding (losses) gains on derivative instruments, net of tax | -$284.0K | $1.5M | $775.0K |
| Reclassification adjustments for gains included in net income, net of tax | -$2.6M | -$3.3M | -$3.2M |
| Total unrealized loss on derivative instruments, net of tax | -$2.9M | -$1.8M | -$2.4M |
| Foreign currency translation adjustments, net of tax | $4.8M | -$269.0K | $929.0K |
| Other comprehensive income (loss) | $1.8M | -$2.0M | -$1.5M |
| Comprehensive income, net of tax | $46.0M | $34.1M | $37.2M |
| Unrealized holding (losses) gains on derivative instruments, income tax expense | $95.0K | $501.0K | $258.0K |
| Reclassification adjustments for gains included in net income, income tax expense | $874.0K | $1.1M | $1.1M |
| Foreign currency translation adjustments, income tax expense | $409.0K | $303.0K | $257.0K |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $122.9M | $124.9M | ||
| Restricted cash | $2.4M | |||
| Accounts receivable, net | $110.6M | $93.5M | ||
| Inventories | $100.3M | $82.4M | ||
| Prepaid expenses | $14.6M | $19.0M | ||
| Other current assets | $15.1M | $7.7M | ||
| Total current assets | $365.9M | $327.6M | ||
| Property and equipment, net | $78.8M | $45.2M | ||
| Operating lease assets | $19.8M | $15.5M | ||
| Deferred tax assets, net | $4.8M | $4.6M | ||
| Intangible assets, net | $115.0M | $107.5M | ||
| Goodwill | $181.4M | $148.2M | $81.7M | |
| Other assets | $4.4M | $4.2M | ||
| Total assets | $770.0M | $652.7M | ||
| Accounts payable | $22.3M | $29.6M | ||
| Accrued liabilities | $61.1M | $46.4M | ||
| Income tax payable | $4.8M | $6.7M | ||
| Current portion of long-term debt | $16.3M | $11.4M | ||
| Total current liabilities | $104.5M | $94.1M | ||
| Long-term debt | $291.0M | $211.8M | ||
| Long-term operating lease liabilities | $15.0M | $10.7M | ||
| Deferred tax liabilities | $30.1M | $18.8M | ||
| Other liabilities | $11.6M | $5.8M | ||
| Total liabilities | $452.2M | $341.2M | ||
| Common stock ($0.0001 par value, 190,000,000 shares authorized, 42,160,656 and 40,607,988 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively) | $4.0K | $4.0K | ||
| Additional paid-in capital | $282.6M | $306.8M | ||
| Accumulated other comprehensive income (loss) | $460.0K | -$1.4M | ||
| Accumulated earnings | $34.8M | $6.1M | ||
| Total shareholders' equity | $317.8M | $311.5M | $197.2M | $165.9M |
| Total liabilities, mezzanine equity and shareholders' equity | $770.0M | $652.7M | ||
| Preferred stock, par value | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 10.0M shares | 10.0M shares | ||
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Common stock, par value | $0.00 | $0.00 | ||
| Common stock, shares authorized | 190.0M shares | 190.0M shares | ||
| Common stock, shares issued | 42.2M shares | 40.6M shares | ||
| Common stock, shares outstanding | 42.2M shares | 40.6M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $122.9M | $124.9M | ||
| Restricted cash | $2.4M | |||
| Accounts receivable, net | $110.6M | $93.5M | ||
| Inventories | $100.3M | $82.4M | ||
| Prepaid expenses | $14.6M | $19.0M | ||
| Other current assets | $15.1M | $7.7M | ||
| Total current assets | $365.9M | $327.6M | ||
| Property and equipment, net | $78.8M | $45.2M | ||
| Operating lease assets | $19.8M | $15.5M | ||
| Deferred tax assets, net | $4.8M | $4.6M | ||
| Intangible assets, net | $115.0M | $107.5M | ||
| Goodwill | $181.4M | $148.2M | $81.7M | |
| Other assets | $4.4M | $4.2M | ||
| Total assets | $770.0M | $652.7M | ||
| Accounts payable | $22.3M | $29.6M | ||
| Accrued liabilities | $61.1M | $46.4M | ||
| Income tax payable | $4.8M | $6.7M | ||
| Current portion of long-term debt | $16.3M | $11.4M | ||
| Total current liabilities | $104.5M | $94.1M | ||
| Long-term debt | $291.0M | $211.8M | ||
| Long-term operating lease liabilities | $15.0M | $10.7M | ||
| Deferred tax liabilities | $30.1M | $18.8M | ||
| Other liabilities | $11.6M | $5.8M | ||
| Total liabilities | $452.2M | $341.2M | ||
| Common stock ($0.0001 par value, 190,000,000 shares authorized, 42,160,656 and 40,607,988 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively) | $4.0K | $4.0K | ||
| Additional paid-in capital | $282.6M | $306.8M | ||
| Accumulated other comprehensive income (loss) | $460.0K | -$1.4M | ||
| Accumulated earnings | $34.8M | $6.1M | ||
| Total shareholders' equity | $317.8M | $311.5M | $197.2M | $165.9M |
| Total liabilities, mezzanine equity and shareholders' equity | $770.0M | $652.7M | ||
| Preferred stock, par value | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 10.0M shares | 10.0M shares | ||
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Common stock, par value | $0.00 | $0.00 | ||
| Common stock, shares authorized | 190.0M shares | 190.0M shares | ||
| Common stock, shares issued | 42.2M shares | 40.6M shares | ||
| Common stock, shares outstanding | 42.2M shares | 40.6M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $44.1M | $36.1M | $38.6M |
| Depreciation and amortization | $18.6M | $16.4M | $15.7M |
| Amortization of original issue discount and debt issue costs | $1.3M | $1.1M | $479.0K |
| Amortization of inventory step-up | $1.3M | $3.9M | |
| Deferred income taxes | $2.4M | -$2.1M | -$210.0K |
| Stock-based compensation | $12.2M | $8.4M | $9.4M |
| Remeasurement of contingent consideration | $1.9M | $1.2M | |
| (Recoveries from) provision for losses on accounts receivable | -$108.0K | $764.0K | $66.0K |
| Unrealized foreign exchange transaction gain | -$2.4M | $1.9M | -$602.0K |
| Other loss (gain) | $390.0K | $496.0K | -$381.0K |
| Accounts receivable | $8.4M | -$24.9M | $6.6M |
| Inventories | -$3.6M | $10.0M | -$10.2M |
| Prepaid expenses and other assets | -$4.5M | -$5.9M | -$302.0K |
| Accounts payable and other liabilities | -$16.4M | -$15.6M | $14.0M |
| Net cash provided by operating activities | $63.7M | $31.8M | $73.2M |
| Purchase of property and equipment | -$6.9M | -$5.7M | -$6.7M |
| Proceeds from disposition of property and equipment | $77.0K | $55.0K | $207.0K |
| Business acquisitions, net of cash acquired | -$89.6M | -$141.8M | |
| Net cash used in investing activities | -$96.4M | -$147.4M | -$6.5M |
| Proceeds from revolving credit facilities | $5.5M | ||
| Principal payments on revolving credit facilities | -$5.5M | ||
| Proceeds from term loans | $97.5M | $129.4M | |
| Principal payments on term loans | -$13.8M | -$43.3M | -$10.0M |
| Proceeds from insurance premium financing | $3.9M | ||
| Principal payments on insurance premium financing | -$2.2M | -$4.0M | |
| Payments for debt issuance costs | -$3.1M | ||
| Taxes paid in connection with employee stock transactions | -$40.2M | -$5.3M | -$2.7M |
| Proceeds from exercise of stock options | $3.4M | ||
| Proceeds from secondary offering, net of underwriter discounts | $91.8M | ||
| Deferred offering costs | -$683.0K | ||
| Dividends distributed | -$15.4M | -$13.9M | -$12.0M |
| Other | $207.0K | $37.0K | $33.0K |
| Net cash provided by (used in) financing activities | $31.6M | $152.7M | -$24.7M |
| Effect of foreign exchange rates on cash, cash equivalents and restricted cash | $1.5M | $224.0K | $438.0K |
| Change in cash, cash equivalents and restricted cash | $394.0K | $37.2M | $42.4M |
| Cash paid for income taxes, net | $24.9M | $24.2M | $8.7M |
| Cash paid for interest | $17.8M | $14.4M | $10.1M |
| Accruals and accounts payable for capital expenditures | $139.0K | $176.0K | $234.0K |
No quarter-by-quarter statement was filed.
Corporate structure
Cadre Holdings, Inc. sits at the top of its group. 41 entities, 11 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Cadre Holdings, Inc.
- Warren B. Kanders Filed SCHEDULE 13D/A on Cadre Holdings, Inc., latest Sep 30, 2026 (10 filings since Feb 14, 2022)
- FMR LLC Filed SCHEDULE 13G/A on Cadre Holdings, Inc., latest Aug 6, 2026 (9 filings since Feb 9, 2023)
- Capital International Investors Filed SCHEDULE 13G/A on Cadre Holdings, Inc., latest May 14, 2026 (2 filings since May 13, 2025)
- REINHART PARTNERS, LLC. Filed SCHEDULE 13G on Cadre Holdings, Inc., latest Feb 12, 2026
- BlackRock Filed SC 13G on Cadre Holdings, Inc., latest Nov 8, 2024 (2 filings since Oct 22, 2024)
- Greenhouse Funds LLLP Filed SC 13G on Cadre Holdings, Inc., latest Feb 14, 2024
- WYNNEFIELD PARTNERS SMALL CAP VALUE LP Filed SC 13G/A on Cadre Holdings, Inc., latest Feb 14, 2023 (2 filings since Feb 14, 2022)
- Cadre Holdings, Inc. Jacksonville, Florida
- Alpha Safety Intermediate, LLC Subsidiary · Delaware, United States
- Atlantic Tactical, Inc. Subsidiary · Pennsylvania, United States
- Bendalls Engineering Limited Subsidiary · United Kingdom
- CT SAS Holdings, Inc. Subsidiary · Delaware, United States
- Cyalume Technologies SAS Subsidiary · France
- Defense Technology, LLC Subsidiary · Delaware, United States
- GH Armor Systems Inc. Subsidiary · Delaware, United States
- Horsepower, LLC Subsidiary · Delaware, United States
- ICOR Technology, Inc. Subsidiary · Canada
- LBA International Limited Subsidiary · United Kingdom
- Med-Eng Holdings ULC Subsidiary · British Columbia, Canada
- Med-Eng, LLC Subsidiary · Delaware, United States
- NFT-EPD, LLC Subsidiary · Colorado, United States
- NucFil, LLC Subsidiary · Colorado, United States
- NuVision Engineering, Inc. Subsidiary · Pennsylvania, United States
- NW Total Engineered Solutions Limited Subsidiary · United Kingdom
- Pacific Safety Products Inc. Subsidiary · Canada
- Pajarito Scientific Corporation Subsidiary · Delaware, United States
- Pajarito Scientific Corporation UK LTD Subsidiary · United Kingdom
- Pajarito Scientific Corporation, Canada Subsidiary · Canada
- Pajarito Scientific Security Corporation Subsidiary · New Mexico, United States
- Radar Leather Division S.r.l. Subsidiary · Italy
- Safariland Distribution, LLC Subsidiary · Delaware, United States
- Safariland Global Sourcing, LLC Subsidiary · Delaware, United States
- Safariland Internacional S.A. de C.V. Subsidiary · Mexico
- and 15 more
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Cadre Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $99.6M8 Dec 31, 2024 | $95.6M8 Dec 31, 2023 | +4.2% |
| Accumulated depreciation | $54.4M8 Dec 31, 2024 | $51.0M8 Dec 31, 2023 | +6.7% |
| Property and equipment, net | $45.2M8 Dec 31, 2024 | $44.6M8 Dec 31, 2023 | +1.3% |
| Finance-lease assets | $2.8M5 Dec 31, 2025 | ||
| Operating-lease assets (leased space) | $19.8M5 Dec 31, 2025 | $15.5M5 Dec 31, 2024 | +28.0% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $122.9M5 Dec 31, 2025 | $124.9M5 Dec 31, 2024 | −1.6% |
| Deposits held (banks) | $32.5M5 Dec 31, 2025 | $10.0M5 Dec 31, 2024 | +224.6% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $181.4M5 Dec 31, 2025 | $148.2M5 Dec 31, 2024 | +22.4% |
| Intangible assets, net (excluding goodwill) | $115.0M5 Dec 31, 2025 | $107.5M5 Dec 31, 2024 | +6.9% |
| Indefinite-lived intangibles (excluding goodwill) | $218.3M5 Dec 31, 2025 | $200.4M5 Dec 31, 2024 | +8.9% |
| Finite-lived intangibles, gross | $200.8M5 Dec 31, 2025 | $183.3M5 Dec 31, 2024 | +9.6% |
| Accumulated amortization | $103.3M5 Dec 31, 2025 | $92.9M5 Dec 31, 2024 | +11.2% |
| Finite-lived intangibles, net | $97.6M5 Dec 31, 2025 | $90.4M5 Dec 31, 2024 | +7.9% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $100.3M5 Dec 31, 2025 | $82.4M5 Dec 31, 2024 | +21.8% |
| Work in process | $10.0M5 Dec 31, 2025 | $8.3M5 Dec 31, 2024 | +20.3% |
Properties, in its own words
We own our corporate headquarters located at 13386 International Parkway, Jacksonville, FL 32218 where we occupy approximately 36,941 square feet of office space and 95,283 square feet of manufacturing space. As of December 31, 2025, we operate facilities in the U.S., Canada, Mexico, United Kingdom, Lithuania, Italy, France, and Germany. Additionally, we lease retail locations across the East Coast that service our Distribution segment. In total, we operate approximately 41 facilities (9 owned) spanning approximately 1,658,448 square feet. Our properties are well maintained, and we consider them to be sufficient for our existing capacity requirements.
The following table summarizes our facilities by segment as of December 31, 2025:
The rest of Item 2
Square Footage
Location · Owned/Leased
Total · Domestic · International · Owned · Leased
Products · 1,600,924 · 702,670 · 898,254 · 573,714 · 1,027,210
Distribution · 57,524 · 57,524 · — · — · 57,524
1,658,448 · 760,194 · 898,254 · 573,714 · 1,084,734
Item 2 of the 10-K filed Mar 10, 2026.4
Leadership
Who has led Cadre Holdings, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
2025
- Chief executive officerWarren B. Kanders Nov 3, 2021 to now12
- ChairWarren B. Kanders Nov 3, 2021 to now12
- PresidentBlaine Browers Aug 17, 2023 to Dec 13, 202313
- Chief financial officerBlaine Browers Nov 3, 2021 to now14
Board members and other officers (6)
- Board memberMary E. Kissel Jun 2, 2026 to now15
- Board memberGianmaria C. Delzanno Jan 16, 2025 to now16
- Board memberDeborah A. Zoullas Apr 14, 2022 to now17
- Board memberHamish Norton Nov 3, 2021 to now18
- Board memberNicolas Sokolow Nov 3, 2021 to now19
- Board memberWilliam G. Quigley Iii. Nov 3, 2021 to now20
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Alpha Safety Intermediate, LLC Delaware3
- Atlantic Tactical, Inc. Pennsylvania3
- Bendalls Engineering Limited England and Wales3
- CT SAS Holdings, Inc. Delaware3
- Cyalume Technologies SAS France3
- Cyalume Technologies, Inc. Delaware3
- Defense Technology, LLC Delaware3
- GH Armor Systems Inc. Delaware3
- Horsepower, LLC Delaware3
- ICOR Technology, Inc. Canada3
- LBA International Limited England and Wales3
- Med-Eng Holdings ULC British Columbia3
- Med-Eng, LLC Delaware3
- NFT-EPD, LLC Colorado3
- NW Total Engineered Solutions Limited England and Wales3
- NuVision Engineering, Inc. Pennsylvania3
- NucFil, LLC Colorado3
- Pacific Safety Products Inc. Canada3
- Pajarito Scientific Corporation Delaware3
- Pajarito Scientific Corporation UK LTD England and Wales3
- Pajarito Scientific Corporation, Canada Canada3
- Pajarito Scientific Security Corporation New Mexico3
- Radar Leather Division S.r.l. Italy3
- Safariland Distribution, LLC Delaware3
All 41 listed subsidiaries
- Safariland Global Sourcing, LLC Delaware3
- Safariland Internacional S.A. de C.V. Mexico3
- Safariland UK Holding Limited England and Wales3
- Safariland UK Ltd. England and Wales3
- Safariland, LLC Delaware3
- SenCan Limited England and Wales3
- Sencan Holdings, LLC Delaware3
- TSG Italy Investment Holdings S.r.l. Italy3
- TSG UK Investment Holdings Limited England and Wales3
- The Safariland Group Hong Kong Limited Hong Kong3
- The Safariland Group Nederland B.V. Netherlands3
- The Safariland Group SPRL Belgium3
- UAB Safariland Lithuania Lithuania3
- United Uniform Distribution, LLC Delaware3
- Wälischmiller Engineering GmbH Germany3
- Zircaloy Engineering US, Inc. Delaware3
- Zircaloy Holdings, LLC Delaware3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Aug 7, 20268-K Results of operations21
- Aug 5, 20268-K Results of operations22
- Jul 29, 20268-K Entered a material agreement; New debt or obligation23
- Jun 3, 20268-K Executive or director change; Shareholder vote24
- May 11, 20268-K Results of operations25
- Mar 10, 20268-K Results of operations26
- Feb 2, 20268-K Entered a material agreement27
- Nov 4, 20258-K Results of operations28
- Nov 3, 20258-K Entered a material agreement29
- Oct 29, 20258-K Regulation FD disclosure30
- Oct 8, 20258-K Regulation FD disclosure31
- Aug 5, 20258-K Results of operations32
- Nov 3, 2021New chief executive Warren B. Kanders becomes CEO12
Calendar
Coming up
- Nov 3, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.27 a share, on Nov 4, 2025.33
When it reported results
- Aug 7, 2026Reported quarterly or annual results21
- Aug 5, 2026Reported quarterly or annual results22
- May 11, 2026Reported quarterly or annual results25
- Mar 10, 2026Reported quarterly or annual results26
- Nov 4, 2025Reported quarterly or annual results28
- Aug 5, 2025Reported quarterly or annual results32
- May 6, 2025Reported quarterly or annual results34
- Mar 11, 2025Reported quarterly or annual results35
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
387 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 49 major events, 168 insider forms, 27 large holders, 123 other. The latest 20:
- Sep 30, 2026SCHEDULE 13D/A EDGAR
- Aug 26, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 25, 2026144 EDGAR
- Aug 24, 2026144 EDGAR
- Aug 19, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 17, 2026144 EDGAR
- Aug 7, 2026EFFECT EDGAR
- Aug 7, 20268-K/A EDGAR
- Aug 6, 2026SCHEDULE 13G/A EDGAR
- Aug 5, 2026S-4/A EDGAR
- Aug 5, 202610-Q EDGAR
- Aug 5, 20268-K EDGAR
- Jul 29, 20268-K EDGAR
- Jun 23, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 18, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 18, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 18, 2026SCHEDULE 13D/A EDGAR
- Jun 18, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 18, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 18, 20264 OWNERSHIP DOCUMENT EDGAR
The 387 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
115 open-market trades by officers, directors and large owners since October 2021: 2 buys and 113 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 100,000 | $31.87 | $3.2M | Form 4 |
| Aug 24, 2026 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 100,000 | $33.36 | $3.3M | Form 4 |
| Aug 17, 2026 | Williams BradPRESIDENT | Sale | 88,742 | $33.24 | $2.9M | Form 4 |
| Jun 22, 2026 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 50,000 | $27.43 | $1.4M | Form 4 |
| Jun 18, 2026 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 25,000 | $27.86 | $696.5K | Form 4 |
| Jun 17, 2026 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 25,000 | $28.68 | $717.0K | Form 4 |
| Jun 16, 2026 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 100,000 | $28.19 | $2.8M | Form 4 |
| Jun 15, 2026 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 100,000 | $30.03 | $3.0M | Form 4 |
| Mar 23, 2026 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 100,000 | $31.93 | $3.2M | Form 4 |
| Mar 20, 2026 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 100,000 | $31.40 | $3.1M | Form 4 |
| Dec 12, 2025 | Browers BlaineCHIEF FINANCIAL OFFICER | Sale | 20,435 | $43.79 | $894.8K | Form 4 |
| Dec 10, 2025 | Williams BradPRESIDENT | Sale | 24,000 | $42.99 | $1.0M | Form 4 |
| Nov 17, 2025 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 1,343,941 | $39.00 | $52.4M | Form 4 |
| Nov 13, 2025 | Williams BradPRESIDENT | Sale | 27,370 | $43.62 | $1.2M | Form 4 |
| Oct 24, 2025 | Williams BradPRESIDENT | Sale | 4,132 | $43.00 | $177.7K | Form 4 |
| Oct 14, 2025 | Williams BradPRESIDENT | Sale | 4,132 | $40.00 | $165.3K | Form 4 |
| Sep 23, 2025 | Williams BradPRESIDENT | Sale | 4,132 | $37.00 | $152.9K | Form 4 |
| Jun 23, 2025 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 25,000 | $32.78 | $819.5K | Form 4 |
| Jun 20, 2025 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 50,000 | $33.01 | $1.7M | Form 4 |
| Jun 18, 2025 | KANDERS WARREN BCEO AND CHAIRMAN | Sale | 50,000 | $33.95 | $1.7M | Form 4 |
All 115 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Warren B. KandersSCHEDULE 13D/A, 10 filings Feb 14, 2022 to Sep 30, 202636
- FMR LLCSCHEDULE 13G/A, 9 filings Feb 9, 2023 to Aug 6, 202637
- Capital International InvestorsSCHEDULE 13G/A, 2 filings May 13, 2025 to May 14, 202638
- REINHART PARTNERS, LLC.SCHEDULE 13G, 1 filing Feb 12, 202639
- BlackRockSC 13G, 2 filings Oct 22, 2024 to Nov 8, 202440
- Greenhouse Funds LLLPSC 13G, 1 filing Feb 14, 202441
- WYNNEFIELD PARTNERS SMALL CAP VALUE LPSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 202342
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 2,936,878 | $83.7M | 0.0% | +310,495 |
| Greenhouse Funds LLLP | 2,868,664 | $81.8M | 4.3% | +286 |
| Reinhart Partners, Llc. | 2,738,373 | $78.1M | 1.8% | +500,476 |
| Fmr LLC | 2,475,623 | $70.6M | 0.0% | −843,573 |
| State Street Corp | 1,949,734 | $55.6M | 0.0% | +553,411 |
| Capital International Investors | 1,622,466 | $46.3M | 0.0% | +361,660 |
| Vanguard Capital Management LLC | 1,324,254 | $37.8M | 0.0% | +76,805 |
| Capital World Investors | 1,205,237 | $34.4M | 0.0% | +32,880 |
| Wynnefield Capital Inc | 1,205,000 | $34.4M | 23.6% | +55,000 |
| Select Equity Group, L.P. | 1,181,921 | $33.7M | 0.2% | +433,423 |
| Brown Advisory Inc | 986,269 | $28.1M | 0.0% | +130,315 |
| Dimensional Fund Advisors LP | 828,520 | $23.6M | 0.0% | +61,447 |
| Geode Capital Management, LLC | 773,516 | $22.1M | 0.0% | +86,662 |
| Morgan Stanley | 729,641 | $20.8M | 0.0% | −22,155 |
| Capital Research Global Investors | 686,030 | $19.6M | 0.0% | +97,740 |
| Bank Of America Corp /de/ | 665,870 | $19.0M | 0.0% | +103,092 |
| First Eagle Investment Management, LLC | 612,916 | $17.5M | 0.0% | New |
| Catawba River Capital | 597,872 | $17.0M | 7.6% | +337,554 |
| Raymond James Financial Inc | 409,158 | $11.7M | 0.0% | −98,080 |
| Invesco Ltd. | 333,171 | $9.5M | 0.0% | +43,353 |
| Northern Trust Corp | 298,942 | $8.5M | 0.0% | −345 |
| Crawford Investment Counsel Inc | 298,843 | $8.5M | 0.1% | +15,801 |
| Agman Capital LLC | 257,409 | $7.3M | 4.6% | +43,681 |
| Vanguard Portfolio Management LLC | 256,869 | $7.3M | 0.0% | +52,411 |
| Charles Schwab Investment Management Inc | 252,147 | $7.2M | 0.0% | +16,683 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
7 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Jun 30, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −10.8% | Report |
| Mar 16, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −35.1% | Report |
| Jun 11, 2025 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −55.1% | Report |
| Apr 17, 2025 | Josh GottheimerDemocratic, House | Sale | $1,001 - $15,000 | +60.8% | Report |
| Jan 27, 2025 | Josh GottheimerDemocratic, House | Buy | $1,001 - $15,000 | −62.6% | Report |
| Dec 27, 2024 | Josh GottheimerDemocratic, House | Sale | $1,001 - $15,000 | +47.4% | Report |
| Dec 6, 2024 | Josh GottheimerDemocratic, House | Buy | $1,001 - $15,000 | −52.7% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
SEC filer profile
How Cadre Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARCadre Holdings, Inc.1
- CIK0001860543
- Employer ID (EIN)38-38731464
- Filer statusAccelerated filer an emerging growth company; not a smaller reporting company; not a shell company4
- Incorporated inDelaware4
- Fiscal year endsDecember 311
- Industry code (SIC)3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address13386 International Pkwy, Jacksonville, FL 322181
- Phone(904) 741-54001
- Shares outstanding42,820,734 as of Jul 31, 202610
- Public float$577.5M as of Jun 30, 20254
- AuditorKPMG LLP, Jacksonville, Florida PCAOB ID 185; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceMay 10, 20211
- Filings408 in all: 4 (150), 8-K (46), 144 (45), CORRESP (18), 424B3 (16), 10-Q (15), 3 (11), UPLOAD (11)1
All 43 form types
SCHEDULE 13G/A (9), S-1/A (8), SC 13G (6), SC 13G/A (6), 10-K (5), DEF 14A (5), EFFECT (5), ARS (4), 4/A (3), 8-K/A (3), S-1 (3), SCHEDULE 13D/A (3), SD (3), 3/A (2), 424B4 (2), 424B5 (2), 424B7 (2), 5 (2), 8-A12B (2), CERT (2), DRS (2), S-1MEF (2), S-8 (2), SCHEDULE 13G (2), DEFA14A (1), DRS/A (1), DRSLTR (1), RW (1), S-3 (1), S-3/A (1), S-3ASR (1), S-3MEF (1), S-4 (1), S-4/A (1), SCHEDULE 13D (1)
- Latest filingsAnnual report (10-K) Mar 10, 2026
Quarterly report (10-Q) Aug 5, 2026
Proxy statement (DEF 14A) Apr 24, 2026
Latest 8-K (8-K) Aug 5, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, $0.0001 Par Value per Share | CDRE | New York Stock Exchange |
From the cover page of the 10-K filed Mar 10, 2026 (Section 12(b) of the Exchange Act).4
Risk factors and legal proceedings
The risks Cadre Holdings, Inc. names in Item 1A of its 10-K filed Mar 10, 2026: 50 risks under these headings, as written.4
- Risks Related to Our Industry
- The products we sell are inherently risky and could give rise to product liability, product warranty claims, and other loss contingencies.
- We are subject to extensive government regulations, and our failure or inability to comply with these regulations could materially restrict our operations and subject us to substantial penalties.
- A reduction in U.S. federal government funding or a shift in spending priorities could have a significant impact on our business, financial condition, results of operations, cash flows, and equity.
- We have significant international operations and assets and, therefore, are subject to additional financial and regulatory risks.
- Changes in global cultural, political, and financial market conditions, including but not limited to tariffs, tax laws and global trade policies, could impair our international operations and financial performance.
- The conflict between Russia and Ukraine and the conflicts in the Middle East, and the potential for these and other geopolitical conflicts to expand or intensify, including through the emergence of additional conflicts or heightened tensions in other regions, could have a material adverse effect on our operations, results of operations, financial condition, liquidity and business outlook.
- Pandemics, epidemics or other disease outbreaks may negatively impact our business operations, financial condition, liquidity, and consolidated results of operations.
- Risks Related to Our Business
- Many of our customers have fluctuating budgets, which may cause substantial fluctuations in our results of operations.
- Because our markets are highly competitive, and our business depends significantly on winning contracts from government customers, if we are unable to compete effectively, we will be adversely affected.
- There are limited sources for some of our raw materials and components, which may significantly curtail our manufacturing operations.
The other 40 risks
- Our resources may be insufficient to manage demand.
- We are dependent on industry relationships.
- We may be unable to protect our proprietary technology.
- Technological advances, the introduction of new products, and new design and manufacturing techniques could adversely affect our operations unless we are able to adapt to the resulting change in conditions.
- We may be adversely affected by applicable environmental, health and safety laws and regulations.
- The effects of climate change, together with increased focus by governmental and non-governmental organizations, customers and investors on sustainability issues, including evolving climate and sustainability related disclosure expectations, may adversely affect our business and financial results and damage our reputation.
- We may lose money or generate less than expected profits on our fixed-price contracts.
- Our Chief Executive Officer has divided responsibilities and is not required to devote any specified amount of time to our business.
- We may be subject to disruptions, failures or cyber-attacks in our information technology systems and network infrastructures that could disrupt our operations, damage our reputation and adversely affect our business, operations, and financial results.
- Our use of emerging technologies (including artificial intelligence) and reliance on third-party service providers could expose us to operational, regulatory, intellectual property, and reputational risks.
- Initiatives to upgrade our business processes and information technology systems to optimize our operational and financial performance involve many risks which could result in, among other things, business interruptions, higher costs and lost profits.
- We rely on information technology systems, including third-party cloud-based solutions, and any failure of these systems, including, without limitation, due to outages and/or cyberattacks, may result in disruptions or outages, loss of processing capabilities, and/or loss of data, any of which may have a material adverse effect on our business, operations, and financial results.
- Misuse of our products may adversely affect the Company’s reputation.
- Adverse publicity about the Company and/or its brands, including without limitation, through social media or in connection with brand damaging events and/or public perception, could negatively impact our business.
- The terms of our outstanding long-term debt and any requirements to incur further indebtedness or refinance our outstanding indebtedness in the future could have a material adverse effect on our business and results of operations.
- Our business is significantly dependent on our ability to meet our labor needs.
- Reductions in the availability of energy supplies or an increase in energy costs may increase our operating costs.
- Our nuclear operations subject us to various environmental, regulatory, financial, and other risks.
- Our business also supplies equipment and services to operators of nuclear energy facilities, including facilities operated by the DoE.
- Our business may suffer if it or its employees are unable to obtain the security clearances or other qualifications needed to perform services for its customers.
- Risks Related to our Acquisition Strategy
- A number of other companies are seeking to make acquisitions in our industry, which may make our acquisition strategy more difficult or expensive to pursue.
- We may be unsuccessful in identifying suitable acquisition candidates, which may negatively impact our competitive position and our growth strategy.
- The due diligence process that we undertake in connection with acquisitions may not reveal all facts that may be relevant in connection with an investment.
- We may face difficulty in integrating the operations of the businesses we have acquired and may acquire in the future.
- We typically retain the management of the businesses we acquire and rely on them to continue running their businesses, which leaves us vulnerable in the event they leave our Company.
- We may be required to take write downs or write-offs, restructuring, and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and our stock price, which could cause you to lose some or all of your investment.
- Risks Related to Ownership of Our Common Stock
- Our executive officers, directors and principal stockholders, if they choose to act together, will continue to have the ability to control all matters submitted to stockholders for approval.
- Shares of our common stock have been, and may continue to be, thinly traded, which may contribute to volatility in our stock price and less liquidity for investors.
- Our stock price may be volatile or may decline regardless of our operating performance, resulting in substantial losses for investors.
- Substantial future sales of shares of our common stock could cause the market price of our common stock to decline.
- If securities or industry analysts do not publish research or reports about our business, or publish negative reports about our business, our share price and trading volume could decline.
- We are an emerging growth company, and any decision on our part to comply only with certain reduced reporting and disclosure requirements applicable to emerging growth companies could make our common stock less attractive to investors.
- Compliance with changing laws, regulations and standards of corporate governance and public disclosure may result in additional expenses.
- Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of our company more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock, which may also have the consequence of depressing the market price of our common stock.
- Our second amended and restated bylaws provide that the Court of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.
- Our payment of future quarterly dividends on our common stock is subject to the discretion and approval of our board of directors.
- We could be subject to securities class action litigation.
- Our amended and restated certificate of incorporation authorizes the issuance of shares of blank check preferred stock.
- We may issue a substantial amount of our common stock in connection with future acquisitions, and the sale of those shares could adversely affect our stock price.
- Techniques employed by short sellers or other derivative traders may drive down the market price of our common stock and/or spur litigation or regulatory action.
Legal proceedings
Refer to Note 15 of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K, which is incorporated herein by reference.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARBlaine Browers, President
- 14
- 15SEC EDGARMary E. Kissel, Board member
- 16SEC EDGARGianmaria C. Delzanno, Board member
- 17SEC EDGARDeborah A. Zoullas, Board member
- 18SEC EDGARHamish Norton, Board member
- 19SEC EDGARNicolas Sokolow, Board member
- 20
- 21SEC EDGARResults of operations
- 22SEC EDGARResults of operations
- 23
- 24
- 25SEC EDGARResults of operations
- 26SEC EDGARResults of operations
- 27SEC EDGAREntered a material agreement
- 28SEC EDGARResults of operations
- 29SEC EDGAREntered a material agreement
- 30SEC EDGARRegulation FD disclosure
- 31SEC EDGARRegulation FD disclosure
- 32SEC EDGARResults of operations
- 33NasdaqNasdaq calendar
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43